Formic Acid

Formic Acid

SCHEMBL31708359

NC(=O)c1csc(-c2cn[nH]c2)n1.O=CO

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 1/20 0.44
▸ HTR2B P41595 1/20 0.43
▸ CYP2C19 P33261 1/20 0.40
▸ ACHE P22303 1/20 0.40
▸ CYP2C9 P11712 1/20 0.40
▸ SCN9A Q15858 1/20 0.40
▸ ALDH1A1 P00352 2/20 0.36
▸ DNM1L O00429 1/20 0.36
▸ IKBKE Q14164 1/20 0.36
▸ TBK1 Q9UHD2 1/20 0.36
▸ HPGDS O60760 1/20 0.35
▸ GPR35 Q9HC97 1/20 0.35
▸ PLK1 P53350 1/20 0.35
▸ AR P10275 1/20 0.35
▸ HDAC1 Q13547 1/20 0.35
▸ HDAC8 Q9BY41 1/20 0.35
▸ HDAC6 Q9UBN7 1/20 0.35
▸ ILK Q13418 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2728413 0.94 HTR2B (0.48) CHEK1HTR2BCYP2C19ACHECYP2C9
Hydrochloric Acid SCHEMBL31122121 0.93 CHEK1 (0.47) CHEK1HTR2BCYP2C19ACHECYP2C9
Phosphoric Acid SCHEMBL31122117 0.89 CHEK1 (0.47) CHEK1HTR2BCYP2C19ACHECYP2C9
Succinic Acid SCHEMBL31122141 0.86 CHEK1 (0.43) CHEK1HTR2BCYP2C19ACHECYP2C9
Cadaverine Tartrate SCHEMBL31122154 0.85 CHEK1 (0.42) CHEK1HTR2BCYP2C19ACHECYP2C9
Cadaverine Tartrate SCHEMBL31122127 0.85 CHEK1 (0.42) CHEK1HTR2BCYP2C19ACHECYP2C9
SCHEMBL3952859 0.81 ALDH1A1 (0.54) CHEK1ACHEALDH1A1DNM1LHPGDS
Citric Acid SCHEMBL31122150 0.80 CHEK1 (0.41) CHEK1HTR2BCYP2C19ACHECYP2C9
SCHEMBL31122153 0.80 CHEK1 (0.48) CHEK1HTR2BCYP2C19ACHECYP2C9
SCHEMBL31122128 0.78 CHEK1 (0.47) CHEK1ALDH1A1DNM1LHPGDSGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250326778-A1 PYRAZOLE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS RIGEL PHARMACEUTICALS, INC. (US) 2025-10-23 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250326778-A1 PYRAZOLE COMPOUNDS AND METHOD FOR MAKING AND USING THE COMPOUNDS IRAK3, IRAK1, IRAK2 CHEK1 414/4885HTR2B 4061/4885CYP2C19 3083/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback